AVITA Medical, Inc. (RCEL): A Bull Case Theory

We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc. (RCEL)'s share was trading at $10.22 as of Feb 19^th.

[caption id="attachment_1235615" align="aligncenter" width="768"] A woman in a lab coat inspecting a vial of medicine for a dermatology drug candidate.[/caption]

Avita Medical (RCEL) reported its Q4 2024 and full-year earnings, with strong revenue growth and expanding market penetration, yet ongoing commercialization efforts continue to weigh on...